Complications in the early postoperative period include bleeding and acute gastric dilatation. Control dilatation by nasogastric
![Pharmaceutics | Free Full-Text | Development and Evaluation of an In Silico Dermal Absorption Model Relevant for Children Pharmaceutics | Free Full-Text | Development and Evaluation of an In Silico Dermal Absorption Model Relevant for Children](https://www.mdpi.com/pharmaceutics/pharmaceutics-14-00172/article_deploy/html/images/pharmaceutics-14-00172-g001.png)
Pharmaceutics | Free Full-Text | Development and Evaluation of an In Silico Dermal Absorption Model Relevant for Children
![Cancers | Free Full-Text | Anti-Cancer Effects of YAP Inhibitor (CA3) in Combination with Sorafenib against Hepatocellular Carcinoma (HCC) in Patient-Derived Multicellular Tumor Spheroid Models (MCTS) Cancers | Free Full-Text | Anti-Cancer Effects of YAP Inhibitor (CA3) in Combination with Sorafenib against Hepatocellular Carcinoma (HCC) in Patient-Derived Multicellular Tumor Spheroid Models (MCTS)](https://pub.mdpi-res.com/cancers/cancers-14-02733/article_deploy/html/images/cancers-14-02733-ag-550.jpg?1654068568)
Cancers | Free Full-Text | Anti-Cancer Effects of YAP Inhibitor (CA3) in Combination with Sorafenib against Hepatocellular Carcinoma (HCC) in Patient-Derived Multicellular Tumor Spheroid Models (MCTS)
![Pharmaceutics | Free Full-Text | Physiologically Based Pharmacokinetic (PBPK) Modeling of Clopidogrel and Its Four Relevant Metabolites for CYP2B6, CYP2C8, CYP2C19, and CYP3A4 Drug–Drug–Gene Interaction Predictions Pharmaceutics | Free Full-Text | Physiologically Based Pharmacokinetic (PBPK) Modeling of Clopidogrel and Its Four Relevant Metabolites for CYP2B6, CYP2C8, CYP2C19, and CYP3A4 Drug–Drug–Gene Interaction Predictions](https://pub.mdpi-res.com/pharmaceutics/pharmaceutics-14-00915/article_deploy/html/images/pharmaceutics-14-00915-g001-550.jpg?1651052755)